Truist Financial’s SpringWorks Therapeutics SWTX Stock Holding History

Truist Financial’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,586	Closed	-$215K	–	2791
2025 Q2	$215K	Sell	4,586 -1,772	-28%	-$78.8K	﹤0.01%	2384
2025 Q1	$281K	Buy	+6,358	New	+$293K	﹤0.01%	2179
2021 Q1	–	Sell	-3,188	Closed	-$231K	–	2723
2020 Q4	$231K	Buy	+3,188	New	+$205K	﹤0.01%	2316

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Truist Financial's SWTX Position: Q3 2025 in Review

Truist Financial sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 4,586 shares — an estimated $215K sold.

Truist Financial first reported a position in SWTX in Q4 2020 and held it in 3 quarters. The position peaked at $281K in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Truist Financial reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Truist Financial sold 4,586 SpringWorks Therapeutics shares in Q3 2025, an estimated $215K.
Truist Financial first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 3 quarters.
Truist Financial's SpringWorks Therapeutics position peaked at $281K in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Truist Financial's 13F filing for Q3 2025, filed 3 Nov 2025.